← Open Payments lookup

LYNN FRAZIER: Open Payments

NPI 1619918505 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$31,775 in 129 payments from 13 companies in 2025. Trend: 2023 $14,211 · 2024 $23,760 · 2025 $31,775

Speaker / faculty: $20,198Travel & lodging: $8,234Food & beverage: $3,342
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc27$15,112
Madrigal Pharmaceuticals31$9,128
Gilead Sciences, Inc.30$6,565
Janssen Scientific Affairs, LLC2$195
ViiV Healthcare Company17$176
Mirum Pharmaceuticals, Inc.1$150
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$118
Novo Nordisk Inc5$106
ABBVIE INC.4$94
Xeris Pharmaceuticals, Inc.2$40

Products named: IQIRVO, REZDIFFRA, Livdelzi, Epclusa, TREMFYA, Livmarli, XIFAXAN, DOVATO.

Industry payments across AR — which companies pay providers there.